InflaRx
IFRX
30 hedge funds and large institutions have $32.1M invested in InflaRx in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 4 closing their positions.
8,280% more call options, than puts
Call options by funds: $419K | Put options by funds: $5K
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
63% more capital invested
Capital invested by funds: $19.7M → $32.1M (+$12.4M)
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
11% more funds holding
Funds holding: 27 → 30 (+3)
0.22% more ownership
Funds ownership: 21.85% → 22.08% (+0.22%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$2.63M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$1.22M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$130K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$53.8K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$43.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EP
Eversept Partners
New York
|
-$2.17M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.08M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$331K |
| 4 |
EGM
Engineers Gate Manager
New York
|
-$30.4K |
| 5 |
Millennium Management
New York
|
-$18.7K |
IFRX Hedge Fund Activity: Q4 2024 in Review
30 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q4 2024, worth a combined $32.1M — up 63% from $19.7M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new IFRX positions and 4 closed out — a net gain of 5 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $2.63M. The largest seller was Eversept Partners, cutting an estimated $2.17M.
- 30 institutional investors held InflaRx (IFRX) as of Q4 2024, up from 27 in Q3 2024.
- Funds reported $32.1M of InflaRx stock for Q4 2024, up 63% quarter-over-quarter.
- 9 funds opened new InflaRx positions in Q4 2024 and 4 closed out, a net change of +5 holders.
- The largest InflaRx buyer in Q4 2024 was Morgan Stanley, an estimated $2.63M added.
- The largest InflaRx seller in Q4 2024 was Eversept Partners, an estimated $2.17M sold.
Based on aggregated 13F filings for Q4 2024.